ArticleEJNMMI radiopharmacy and chemistry2026
Co-57-based intercomparison of TLC scanners and dose calibrators for low-activity radiochemical purity assessment in radiopharmaceutical quality control.
Article in EJNMMI radiopharmacy and chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThin layer chromatography scanners and dose calibrators are commonly used to assess radiochemical purity of radiopharmaceutical preparations. Strict quality assurance programs surveyed by regulatory bodies exist for dose calibrators, but they primarily focus on clinical activity ranges, typically tens to hundreds of megabecquerels (MBq). These programs are not designed to evaluate performance at the lower activity levels used during radiopharmaceutical quality control, in the range of just a few MBq or less. For thin layer chromatography scanners, to our knowledge, no supervised quality control program exists. As a result, current practices may overlook potential inaccuracies at these low but critical activity levels, potentially affecting the reliability of radiochemical purity assessments, guaranteeing radiopharmaceutical quality of patient injections.
resultsTo address this gap, in collaboration with the Swiss Federal Office of Public Health, we organized an intercomparison campaign for radiochemical purity testing employing in-house fabricated cobalt-57 (Co-57) strips simulating a chromatogram of a radiopharmaceutical preparation for quality control. Co-57, with its longer half-life, closely simulates the gamma emissions of technetium-99m (Tc-99m), a nuclide widely used in nuclear medicine. Co-57 thin layer chromatography strips were prepared and characterized, before being sent to nuclear medicine centers for measurement and radiochemical purity assessment. 31 centers participated, in total 41 quality control measurements were performed using dose calibrators and/or thin layer chromatography scanners to assess the radiochemical purity. All 27 dose calibrator results were within specifications, except for one result that overestimated the radiochemical purity. Within 14 thin layer chromatography scanner results, 3 were out of tolerance.
conclusionRegular participation in intercomparison campaigns is essential for harmonizing practices and ensuring reproducible, reliable results. Thin layer chromatography results can be affected by scanner settings, procedural variations, and subjective peak integration. By comparing thin layer chromatography scanners and dose calibrators, we identified potential instrument biases and methodological discrepancies when values were out of tolerance. Our intercomparison contributed to improving the performance and comparability of radiochemical purity measurements across Swiss nuclear medicine institutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.